# DIDO satellites

> Cubesats by space pharma for biological experiments in micro gravity

**Wikidata**: [Q28735708](https://www.wikidata.org/wiki/Q28735708)  
**Source**: https://4ort.xyz/entity/dido-satellites

## Summary
DIDO satellites are CubeSats developed by Space Pharma for conducting biological experiments in microgravity. Launched in 2017, these miniaturized satellites are part of the uGnify program and were deployed in low Earth orbit using the Polar Satellite Launch Vehicle.

## Key Facts
- **Instance of**: Artificial satellite
- **Subclass of**: CubeSat (miniaturized satellite made up of 10cm-sided cubic modules)
- **Aliases**: DIDO-1, DIDO-2, uGnify
- **Launch date**: February 15, 2017
- **Orbit**: Low Earth orbit
- **Launch vehicle**: Polar Satellite Launch Vehicle (developed by the Indian Space Research Organisation)
- **Primary purpose**: Biological experiments in microgravity
- **Website**: [https://www.spacepharma.health/](https://www.spacepharma.health/)
- **Wikipedia availability**: Only in Hebrew (he)

## FAQs
### Q: What are DIDO satellites used for?
A: DIDO satellites are CubeSats designed by Space Pharma to conduct biological experiments in microgravity. They are part of the uGnify program and were launched to study the effects of space environments on biological samples.

### Q: Who developed the DIDO satellites?
A: The DIDO satellites were developed by Space Pharma, a company specializing in space-based pharmaceutical and biological research.

### Q: What type of orbit do DIDO satellites operate in?
A: DIDO satellites operate in low Earth orbit, which is a common orbit for CubeSats and small satellites.

### Q: Which launch vehicle was used to deploy the DIDO satellites?
A: The DIDO satellites were launched using the Polar Satellite Launch Vehicle (PSLV), an expendable launch system developed by the Indian Space Research Organisation (ISRO).

### Q: Are there multiple versions of the DIDO satellites?
A: Yes, the DIDO satellites include versions such as DIDO-1 and DIDO-2, part of the broader uGnify program.

## Why It Matters
DIDO satellites represent a significant advancement in space-based biological research, allowing scientists to study the effects of microgravity on biological samples in a controlled environment. By leveraging CubeSat technology, Space Pharma has made it possible to conduct experiments that were previously only feasible on larger, more expensive satellites. The DIDO satellites contribute to the broader field of space medicine and pharmaceutical research, potentially leading to breakthroughs in understanding how biological systems respond to space conditions. Their deployment via the Polar Satellite Launch Vehicle also highlights the growing collaboration between international space agencies and private companies in advancing space exploration and research.

## Notable For
- **First of their kind**: Among the first CubeSats dedicated to biological experiments in microgravity.
- **Multi-version program**: Includes DIDO-1 and DIDO-2, part of the uGnify initiative.
- **Low-cost research**: Enables biological studies in space using miniaturized satellite technology.
- **International collaboration**: Launched via the Polar Satellite Launch Vehicle, developed by the Indian Space Research Organisation.
- **Space medicine innovation**: Contributes to understanding biological responses in space environments.

## Body
### Overview
DIDO satellites are a series of CubeSats developed by Space Pharma for biological experiments in microgravity. The program includes versions such as DIDO-1 and DIDO-2, collectively known as uGnify. These satellites are part of a broader effort to advance space-based pharmaceutical and biological research.

### Technical Specifications
- **Type**: CubeSat (miniaturized satellite made up of 10cm-sided cubic modules)
- **Orbit**: Low Earth orbit
- **Launch vehicle**: Polar Satellite Launch Vehicle (PSLV), developed by the Indian Space Research Organisation

### Launch and Deployment
- **Launch date**: February 15, 2017
- **Deployment**: Launched into low Earth orbit using the PSLV, a reliable and frequently used launch vehicle for small satellites.

### Purpose and Research
- **Primary mission**: Conduct biological experiments in microgravity to study the effects of space environments on biological samples.
- **Significance**: Enables research that was previously only possible on larger, more expensive satellites, making space-based biological studies more accessible.

### Collaborations and Partnerships
- **Launch provider**: Polar Satellite Launch Vehicle (PSLV), developed by the Indian Space Research Organisation (ISRO), facilitating the deployment of DIDO satellites.
- **Research focus**: Contributes to the field of space medicine and pharmaceutical research, potentially leading to breakthroughs in understanding biological systems in space.

### Wikipedia and Public Availability
- **Wikipedia presence**: Only available in Hebrew (he) as of the provided data.
- **Website**: [https://www.spacepharma.health/](https://www.spacepharma.health/) for further information.